PRA Health Sciences Selected by BARDA to be a Member of its Exclusive Clinical Studies Network

RALEIGH, N.C., Oct. 6 (Korea Bizwire) — PRA Health Sciences, Inc. (NASDAQ: PRAH) announced today it has been selected by the Biomedical Advanced Research and Development Authority (BARDA) to be a member of its updated Clinical Studies Network (CSN). Under a Clinical Trial Planning and Execution (CTPE) contract award, PRA will serve as a valued [...]